Promising Strategies for Assessing Risk and Detecting Recurrence Earlier
Dr. Bardia discusses promising biomarkers and strategies for helping assess risk and detect recurrence in breast cancer.
EP: 1.Best Practices for Assessing Risk of Recurrence in Patients with Breast Cancer
EP: 2.Clinical Evidence Supporting the use of ctDNA to Detect Recurrence
EP: 3.Data Review: ctDNA Monitoring in Patients with Breast Cancer
EP: 4.Practical Clinical Applications for ctDNA Assessment
EP: 5.Technical and Logistical Challenges Concerning the use of ctDNA Monitoring
Now Viewing
EP: 6.Promising Strategies for Assessing Risk and Detecting Recurrence Earlier
Related Videos
Related Content
